22 employees
AltruBio is focused on developing targeted antibody therapeutics for the treatment of cancer and immune related inflammatory diseases.
2020
$63M
from 1 investors over 1 rounds
AltruBio Inc. raised $63M on April 15, 2021
Investors: aMoon Fund